• Samuel J Youssef, Brian E Louie, Alexander S Farivar, Maurice Blitz, Ralph W Aye, and Eric Vallières.
• Swedish Cancer Institute and Medical Center, 1101 Madison St., Suite 850, Seattle, WA, USA.
• Am. J. Surg. 2010 May 1; 199 (5): 589-93.

BackgroundMost thymectomies are performed via sternotomy. Minimally invasive thymectomy (MIT) has been described but its potential benefits and drawbacks remain unclear.MethodsA retrospective chart review comparing thymectomies performed via sternotomy to MIT at a single institution between 2005 and 2009.ResultsEight patients underwent MIT and 8 patients underwent sternotomy in the management of myasthenia gravis, thymic hyperplasia, or small thymic tumors. There was 1 perioperative death unrelated to the surgical procedure and no morbidity. The surgical time, estimated blood loss, and chest tube output was similar in both groups. The average hospital stay for MIT was 2.4 days compared with 4.3 days for sternotomy. One MIT patient remained on narcotic pain medication 2 weeks after surgery compared with 6 in the open group.ConclusionsMIT can be performed with similar morbidity and efficacy as transsternal thymectomy. Patients require fewer narcotics and can be discharged earlier.Copyright 2010 Elsevier Inc. All rights reserved.

43 keywords...

hide…